Product Description: Suritozole (MGL-26479) is a cognitive enhancer that acts as a partial inverse agonist of benzodiazepine receptor sites on GABAA ion channel complexes. Suritozole can be used in the study of neurodegenerative diseases[1].
Formula: C10H10FN3S
References: [1]O'Dell DM, et al. Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury. J Neurosurg. 1995 Nov;83(5):878-83.
CAS Number: 110623-33-1
Molecular Weight: 223.27
Research Area: Neurological Disease
Solubility: 10 mM in DMSO
Target: GABA Receptor